Suchergebnisse - (Person:"Wei, Xiang")

PubPharm (10)

1

Risk of interstitial lung disease associated with EGFR-TKIs in advanced non-small-cell lung cancer : a meta-analysis of 24 phase III clinical trials

enthalten in: Journal of chemotherapy (Florence, Italy) | 2015

von Qi, W. | Sun, Y. | Shen, Z. | +1

2

Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer : a meta-analysis of 17 phase III randomized controlled trials

enthalten in: Current medical research and opinion | 2015

von Qi, W. | Fu, S. | Zhang, Q. | +1

3

Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors : an up-to-date meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

4

Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors : a systematic review and meta-analysis of 36 clinical trials

enthalten in: British journal of clinical pharmacology | 2014

von Qi, W. | Shen, Z. | Tang, L. | +1

5

Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors : a systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2014

von Qi, W. | Sun, Y. | Tang, L. | +2

6

Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients : a systematic review and meta-analysis

enthalten in: British journal of clinical pharmacology | 2013

von Qi, W. | He, A. | Shen, Z. | +1

7

Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs : a meta-analysis of 22 phase III randomized controlled trials

enthalten in: Respiratory medicine | 2013

von Qi, W. | Tang, L. | He, A. | +2

8

Risk of venous thromboembolic events associated with VEGFR-TKIs : a systematic review and meta-analysis

enthalten in: International journal of cancer | 2013

von Qi, W. | Min, D. | Shen, Z. | +5

9

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients : a meta-analysis

enthalten in: PloS one | 2013

von Qi, W. | Huang, Y. | Yao, Y. | +2

10

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer : a systematic review and meta-analysis

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2012

von Qi, W. | Shen, Z. | Lin, F. | +5

1
[1]